FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs – fda.gov

1. FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs  fda.gov
2. US set to speed up approval for some generic drugs in blow to Big Pharma  Financial Times
3. What Impact will FDA’s ANDA Prioritization Pilot have on the Global Supply Chain?  Pharmaceutical Executive
4. US FDA plans to accelerate biosimilar approvals, FT reports  Reuters
5. FDA makes major move to reduce regulatory red tape for biosimilars  Endpoints News

Continue Reading